Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to prevent heavy bleeding after childbirth in women at higher risk
PACTR202305473136570Phase 3Recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3 trial of tranexamic acid in postpartum hemorrhage (PPH) (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Clinical diagnosis of postpartum haemorrhage and Haemodynamic instability related to postpartum bleeding. Started Aug 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202305473136570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202305473136570.